Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Aug;152(2):365-367.
doi: 10.1016/j.jaci.2023.06.010. Epub 2023 Jun 21.

Glimpses into treating GLILD

Affiliations
Editorial

Glimpses into treating GLILD

Timi Martelius et al. J Allergy Clin Immunol. 2023 Aug.
No abstract available

Keywords: Interstitial lung disease; common variable; glucocorticoids; granulomatous-lymphocytic interstial lung disease; immunodeficiency; immunomodulatory therapy; inborn errors of immunity; primary immunodeficiencies.

PubMed Disclaimer

Comment on

  • The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease.
    Smits B, Goldacker S, Seneviratne S, Malphettes M, Longhurst H, Mohamed OE, Witt-Rautenberg C, Leeman L, Schwaneck E, Raymond I, Meghit K, Uhlmann A, Winterhalter C, van Montfrans J, Klima M, Workman S, Fieschi C, Lorenzo L, Boyle S, Onyango-Odera S, Price S, Schmalzing M, Aurillac V, Prasse A, Hartmann I, Meerburg JJ, Kemner-van de Corput M, Tiddens H, Grimbacher B, Kelleher P, Patel SY, Korganow AS, Viallard JF, Tony HP, Bethune C, Schulze-Koops H, Witte T, Huissoon A, Baxendale H, Grigoriadou S, Oksenhendler E, Burns SO, Warnatz K. Smits B, et al. J Allergy Clin Immunol. 2023 Aug;152(2):528-537. doi: 10.1016/j.jaci.2022.12.813. Epub 2022 Dec 29. J Allergy Clin Immunol. 2023. PMID: 36587851 Clinical Trial.

LinkOut - more resources